chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient has all the side effects listed; This spontaneous case was reported by an other caregiver and describes the occurrence of VACCINATION COMPLICATION (patient has all the side effects listed) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) unknown. On an unknown date, the patient experienced VACCINATION COMPLICATION (patient has all the side effects listed). At the time of the report, VACCINATION COMPLICATION (patient has all the side effects listed) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
sore arm; general achiness; The initial case was missing the following minimum criteria: no adverse effect. Upon receipt of follow-up information on [16Mar2021], this case now contains all required information to be considered valid.  This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (002191). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 19Jan2021 22:30 (Lot number: EL1283, Expiration Date: 19Jan2021) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021 (onset time reported as 05:00 PM), outcome "unknown", described as "sore arm"; PAIN (non-serious) with onset 2021 (onset time reported as 05:00 PM), outcome "unknown", described as "general achiness".  No follow-up attempts are possible. No further information is expected.
On 10/27/2021, 7 mins after the injection, I blackout, passed out cold. I finally came through. My heart was racing and palpitating. Someone drove me home. The next day, and all that day I had heart palpitations, and my heart was racing. On Saturday along with the heart issues. I was also starting to get shortness of breath. I started getting pressure in my chest. Then I started getting pain in my chest. On, Tuesday, 11/02/2021, Everything kept getting worse I had shortness of breath. I passed out again. On Tuesday, my husband took me to the ER room. We were there for like 10 to 11 hours. The doctor ruled out myocarditis and blood clot in the lungs. The ER doctor said my symptoms fit pericarditis. But he wants me to confirm with a cardiologist. Right now, I am working on an appointment with a cardiologist.
Information has been received from a medical assistant concerning a 16 year old female patient who on 23-SEP-2009 was vaccinated with her initial dose of GARDASIL (Lot # not provided). Concomitant therapy included VARIVAX (MSD). Other concomitant therapy included influenza virus vaccine (unspecified). The medical assistant reported that the patient received GARDASIL on 23-SEP-2009 and the next day the patient developed a red spot on her arm about a size of half a dollar coin and that it was raised, round spot and it was warm to the touch. The medical assistant reported that the patient was treated with BENADRYL and ice and within 30 hours, the inflammation was reduced and after 48 hours the spot was gone. The patient sought medical attention by calling the physician's office. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a adult male patient who received SHINGRIX. Concurrent medical conditions included pruritus and pain. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patent experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not provided. The wife reported that her husband got a SHINGRIX vaccine about a month ago and experienced arm hurting for about 2 to 3 days after the injection. She does not have any other details of the vaccine. She stated her husband was a pharmacist. She did not believe he had reported this, as it was pretty common side effect. This case has been linked with case US2018093518 reported by the same reporter.
Tinnitus in left ear, no treatment available that I know of, no resolution at 12 days
Fever, Irritability, lack of appetite, sleepiness, puking and diarrhea.  He received shots Monday morning (11/02/2015) and showing side effects Monday night and now just getting back to normal Thursday(11/05/2015).
sores on his scalp, face, legs, back and abdomen; She stated that it is extra red; seems like this shot has now flared up his eczema; next week it was completely flared up, with swelling; very bad rash/ it was completely flared up; He got his 2nd dose two weeks apart because that is what his pharmacy told him to do.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (sores on his scalp, face, legs, back and abdomen), RASH ERYTHEMATOUS (She stated that it is extra red), ECZEMA (seems like this shot has now flared up his eczema), SWELLING (next week it was completely flared up, with swelling) and RASH (very bad rash/ it was completely flared up) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Eczema (Patient was born with eczema.).   In August 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In September 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In September 2021, the patient experienced PAIN (sores on his scalp, face, legs, back and abdomen), RASH ERYTHEMATOUS (She stated that it is extra red), ECZEMA (seems like this shot has now flared up his eczema), SWELLING (next week it was completely flared up, with swelling), RASH (very bad rash/ it was completely flared up) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He got his 2nd dose two weeks apart because that is what his pharmacy told him to do.). The patient was treated with CORTISOL [HYDROCORTISONE] for Adverse event, at an unspecified dose and frequency. In September 2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He got his 2nd dose two weeks apart because that is what his pharmacy told him to do.) had resolved. At the time of the report, PAIN (sores on his scalp, face, legs, back and abdomen), RASH ERYTHEMATOUS (She stated that it is extra red), ECZEMA (seems like this shot has now flared up his eczema), SWELLING (next week it was completely flared up, with swelling) and RASH (very bad rash/ it was completely flared up) had not resolved.            No concomitant medications were reported  It was reported that he got the 1st dose of the Moderna COVID 19 vaccine approximately at the end of August - 28th, 29th or 30th.  He had no reactions  It was reported events still ongoing.  It was reported that he  hasn't been treated for it since doctors did not  know what was going on. Three doctors in their area refused to treat him because they did not  know what to do. Only one dermatologist gave him a cortisol shot.  It was reported that the patient was born with eczema. He was not taking any medication for it, it has been under complete control for more than 10 years
Severe frontal headache starting about 2 hours post second dose of Moderna. Patient states this is a 24 hour headache, waking him up at night. Has not resolved since May. Tried Tylenol #3 for pain. No relief.
This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient previously received covid-19 vaccine ad26. cov2.s (dose number in series 1) (initial dose) (suspension for injection, route of admin was not reported, batch number: unknown, expiry: unknown) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis. It was unknown if the patient experienced any adverse events following administration of covid-19 vaccine ad26. cov2.s (dose number in series 1). The patient received first booster dose of covid-19 vaccine ad26. cov2.s (dose number in series 2) (suspension for injection, route of admin was not reported, batch number: unknown, expiry: unknown) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis. It was unknown if the patient experienced any adverse events following administration of covid-19 vaccine ad26. cov2.s (dose number in series 2). The patient additionally received second booster dose of covid-19 vaccine ad26.cov2.s (dose number in series 3) (suspension for injection, route of admin was not reported, batch number: unknown, expiry: unknown) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis which was off label dosing frequency. The drug was associated with off label use (dose number in series 3). The batch number was not reported and has been requested. No concomitant medications were reported.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of off label dosing frequency was not reported. This report was non-serious.
Soreness on my shoulder where they gave me the shot; I felt liquid down my arm when he pulled it out. Then he was still squeezing liquid out.; I felt liquid down my arm when he pulled it out. Then he was still squeezing liquid out.; I felt liquid down my arm when he pulled it out. Then he was still squeezing liquid out.; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 63-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection) via an unspecified route of administration, administered in arm on unspecified date in Feb2021 (at the age of 63-years-old) as single dose for COVID-19 immunization. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) administered on an unspecified date in Jan2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date in Feb2021, the second vaccine a young man gave him the shot and he stuck it in faster than he had ever seen. He felt liquid down his arm when he pulled it out. Then he was still squeezing liquid out (at the time of report). Patient asked if there was a test to see if he received the full dose. Upon follow-up on 23Jul2021, the patient stated that he felt as if the vaccination provider had put in the needle very quickly and felt as if some of the vaccine had dripped out when removing the needle, perhaps didn't receive a full second vaccination and also reported that gave him the shot it was a real quick, when he pulled it out felt some liquid hit his arm, his shoulder, saw some stuff coming out the needle, not confident that he got the full dose on that second shot. On unknown date, patient experienced soreness on his shoulder where they gave the shot. Patient could not provide the date of administration and LOT# as the vaccination card is not with the consumer. Consumer stated regarding concomitant medication as no and he had taken is some over the counter Advil and Tylenol at different points. Patient inquired that whether he need another shot or is it enough which he got already. Outcome of the events were unknown.  Information on lot/batch number has been requested.  Follow-up (23Jul2021): New information received from contactable consumer (patient) via Pfizer-sponsored program includes: patient weight and height, age at time of onset of reaction, event (Soreness on my shoulder where they gave me the shot) added and clinical information updated.
Pt recvd vax in the evening 24 hrs p/vax devel a rash that covered the entire neck from chin to clavicular area; the rash also itched; treated w/DPH cream;
On the evening of 1/25/21, one week after receiving the vaccine, my upper left arm became itchy--I looked & discovered a red, mildly itchy bump at the injection site. I applied cortisone cream, which relieved the itch. The next day (1/26) it was still red & mildly itchy. I applied cortisone cream in the morning & evening & took one Benadryl tablet before bed. The next morning (1/27), still the same. Applied cortisone cream. It was a bit better by evening, no additional cortisone cream needed. The next day, much less red & not itchy at all.  (Note that the only reaction when I got the vaccine on 1/18/21 was very mild soreness for a day or two, no itching).
Patient complains of diaphoresis and lightheadedness.  EMS called.  Patient symptoms subsided after lying back and following breathing techniques.  Patient left.
Client's mother stated a rash appeared to upper shoulders after receiving vaccines 8/17/15 and rash appeared to back, upper shoulders and chest after receiving vaccines 10/19/15.
Within a week of receiving the first vaccine, an oral herpes outbreak occured. When received the second dose the outbreak occured within hours. Have had these outbreaks for years usually 1 or 2x per year; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727), via an unspecified route of administration in the left arm on 24Mar2021 at 10:00 (at the age of 70-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731), via an unspecified route of administration in the left arm on 14Apr2021 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. Medical history included non-Hodgkin's lymphoma and it was in remission for 4 years. The patient did not have any allergies to medications, food or other products. Concomitant medications included valaciclovir (VALACYCLOVIR) 1000 mg, trazodone (MANUFACTURER UNKNOWN) 100 mg and estrogen nos (BIOIDENTICAL); all from unknown dates for unspecified indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, within a week of receiving the first vaccine, the patient experienced an oral herpes outbreak. On 14Apr2021, when the patient received the second dose, the outbreak occurred within hours. The patient usually had these outbreaks once or twice a year. It was reported that the patient took valacyclovir both the times. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event which included treatment with valacyclovir. The clinical outcome of the event within a week of receiving the first vaccine, an oral herpes outbreak occurred, when received the second dose the outbreak occurred within hours was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
No other AEs reported; vaccine administered after temperature excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided.       On 25-SEP-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 milliliter, subcutaneous, lot number U015689, expiration date reported as 13-MAY-2023 but upon internal validation was determined as 18-MAY-2021 for prophylaxis. No adverse event was reported.  The vaccine underwent a temperature excursion of 25.9 degrees Farhrenheit for 1 hour and 30 minutes. No previous temperature excursions were detected.
Chief Complaint:  Cough and Chest Pain    Source of Information:  Patient and spouse at bedside    History of Present Illness:  This is a 57y.o. male with a history of asthma, COPD, HTN, psoriasis, chronic back pain, dyslipidemia, morbid obesity and OSA who presents to local-ED with chief complaint of SOB and chest pain. Patient states that these symptoms started 4 days ago. He admits to a non-productive cough and chest pain that is worse with coughing. He states his chest pain is left-sided and sometimes radiates to the right side of his chest. Patient admits to headaches, lightheadedness, generalized abdominal pain, mild nausea and a decrease in sleep for the past 4 days. Patient states that he has been taking Robitussin and DayQuil without relief. Patient is vaccinated against COVID, but has not received the booster. He states that he started vaping a few months ago, and that he takes ~5 hits daily. He also admits to drinking alcohol, approximately 2-3 shots of liquor per week, and occasional marijuana use. Denies fevers, chills, vomiting, diarrhea, constipation or lower extremity edema.    ED course:
On 1/2/2023, at approximately 12:00 AM, I was lying in bed, and I felt very short of breath. I spent the next six hours sitting at a 90-degree angle, dozing intermittently. At 6:00 AM, I drove myself to the ER. At the ER, I spent approximately six hours. I was tested for COVID-19 and influenza. I tested negative for COVID-19 and positive for influenza. I was given SOLUMEDROL intravenously and a breathing treatment with a steroid whose name I don't know. I was then discharged and given a prescription for prednisone at 40 mg, which I was to take daily for seven days. I followed up with my PCP two weeks later, at which time it was discovered that I was in atrial fibrillation. The PCP began treating me with digoxin and CARDIZEM. At this point, my heartrate was 140, and they wanted to get it down. I returned to the PCP five days later. I was then given XARELTO, LASIX, and potassium. I was then referred to a cardiologist, whom I was scheduled to see in four months' time. Two weeks later, I ended up back in the ER on 2/13/2023, because I had shortness of breath. The ER gave me a referral to another cardiologist, whom I saw on 2/14/2023. The cardiologist discontinued the CARDIZEM and digoxin and prescribed me metoprolol. On 2/15/2023, I underwent a stress test and an echocardiogram. The results indicated that I did not have heart disease and that I just had atrial fibrillation. I then saw the cardiologist again on 3/9/2023. We discussed why I had atrial fibrillation, since I had never had cardiac trouble before. He explained that there were now all sorts of new bugs, such as COVID-19, nowadays and that their long-term effects aren't really known at this point. He then said that he would not be surprised if the atrial fibrillation had been brought on by the influenza. On 3/28/2023, I underwent an esophageal echocardiogram and two cardioversions. I then went into regular sinus rhythm, which lasted until 4/1/2023. I woke up at about 3:00 AM with shortness of breath, and I knew that I had atrial fibrillation again. I spoke to the cardiologist, who wanted to schedule me for an ablation, but I would not be able to undergo the ablation until September or October 2023. I then began calling other medical centers and found out about a cardiologist in another city. I spoke with this cardiologist, who informed that there are two types of ablation: cryoablation and radio frequency ablation. I saw the cardiologist on 4/13/2023, and he scheduled me to undergo a cryoablation on 4/26/2023. I underwent the ablation as scheduled, and I have been in normal sinus rhythm ever since. He also started me on two new medications: flecainide and colchicine. I am scheduled for a follow-up appointment with the cardiologist on 5/9/2023.
Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not reported. On 13-MAR-2018, the patient was vaccinated with an expired stored properly dose of PNEUMOVAX23 (batch/lot # M020521, expiration date 17-NOV-2017; dose and route were not provided) for prophylaxis (expired vaccine used). No adverse effects were reported.
Right arm redness, swelling, hot to the touch, itchiness, soreness. Given ibuprofen, no resolution.
This case was reported by a pharmacist and described the occurrence of nausea in three subjects of unspecified ages and genders who were vaccinated with ENGERIX B, (GlaxoSmithKline).  On the morning of 10 July 2008, the subjects received unspecified doses of ENGERIX B (unknown).  After an unspecified amount of time following vaccination with ENGERIX B, on the morning of 10 July 2008, the subjects experienced nausea.  All three subjects received doses of ENGERIX B from lot #AHBVB584AA; expiration date 06 November 2010.  At the time of reporting, the events were unresolved.  No further information was available at the time of this report.
I started having chest pain periodically. It felt like a muscle contraction. It was for a few days. I had pain in my upper left arm that was there for several days before. On the 21st I experienced shortness of breath. I got short of breath carrying groceries to the car. I also had pain in my jaw. I also had fever, chills, and achiness the day following vaccination. My D-dimer test came back abnormal. I was given a CAT scan for blood clots. This afternoon I have a stress test and they want to do a Holter monitor. I continue to have fatigue and shortness of breath episodes.